DUBLIN–(BUSINESS WIRE)–The “Trypanosomiasis
– Global Clinical Trial Pipeline Highlights, 2019” report has
been added to ResearchAndMarkets.com’s offering.
This report provides most up-to-date information on key pipeline
products in the global Trypanosomiasis market. It covers emerging
therapies for Trypanosomiasis in active clinical development stages
including early and late stage clinical trials.
The pipeline data presented in this report helps executives in tracking
competition, identifying partners, evaluating opportunities, formulating
business development strategies, and executing in-licensing and
out-licensing deals.
Clinical Trial Stages
The report provides Trypanosomiasis pipeline products by clinical trial
stages including both early and late stage development – phase 3
clinical trials, phase 2 clinical trials, phase 1 clinical trials,
preclinical research, and discovery stage.
Drug Mechanism Classes
The report provides Trypanosomiasis pipeline products by their dominant
mechanism of action/drug class. This helps executives categorize
products based on their drug class and also assess the strengths and
weaknesses of compounds.
Company
The report provides Trypanosomiasis pipeline products by the company.
Short-term Launch Highlights
Find out which Trypanosomiasis pipeline products will be launched in the
US and Ex-US to 2024.
Key Topics Covered
1. Trypanosomiasis Pipeline by Stages
2. Trypanosomiasis Phase 3 Clinical Trial Insights
3. Trypanosomiasis Phase 2 Clinical Trial Insights
4. Trypanosomiasis Phase 1 Clinical Trial Insights
5. Trypanosomiasis Preclinical Research Insights
6. Trypanosomiasis Discovery Stage Insights
7. Appendix
8. Research Methodology
List of Tables
Table 1: Trypanosomiasis Phase 3 Clinical Trials, 2019
Table 2: Trypanosomiasis Phase 2 Clinical Trials, 2019
Table 3: Trypanosomiasis Phase 1 Clinical Trials, 2019
Table 4: Trypanosomiasis Preclinical Research, 2019
Table 5: Trypanosomiasis Discovery Stage, 2019
List of Figures
Figure 1: Trypanosomiasis Pipeline Molecules by Clinical Trials Stage,
2019
Figure 2: Trypanosomiasis Phase 3 Clinical Trial Highlights, 2019
Figure 3: Trypanosomiasis Phase 2 Clinical Trial Highlights, 2019
Figure 4: Trypanosomiasis Phase 1 Clinical Trial Highlights, 2019
Figure 5: Trypanosomiasis Preclinical Research Highlights, 2019
Figure 6: Trypanosomiasis Discovery Stage Highlights, 2019
For more information about this report visit https://www.researchandmarkets.com/r/gibn3c
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Infectious
Diseases Drugs, Clinical
Trials